Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. John’s Wort

This article was originally published in The Tan Sheet

Executive Summary

A systematic review of prospective clinical trials evaluating the pharmacokinetic effect of St. John's Wort on the metabolism of conventional drugs found 17 of 19 trials with available plasma data showed a decrease in bioavailability of the conventional drug. The review by Edward Mills, McMaster University Hamilton, Ontario, et al., looked at 22 pharmacokinetic trials overall, averaging 12 participants. The report, published in the July 3 British Medical Journal, concludes that clinicians and patients "should beware of possible decreases in the systemic bioavailability of conventional drugs" taken with the botanical...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS097050

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel